Astro-Med, Inc. 10-Q Filing Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Astro-Med, Inc., a manufacturer of data acquisition, digital color printing, and neurophysiology products. The report covers the quarterly period ended August 1, 1998, and the six-month period ended on the same date. The company is incorporated in Rhode Island.
Key Financial Metrics
| Metric | Three Months Ended Aug 1, 1998 | Six Months Ended Aug 1, 1998 |
|---|---|---|
| Net Sales | $10,528,111 | $20,584,551 |
| Gross Profit | $4,269,181 | $8,144,788 |
| Gross Margin | 41% | 40% |
| Operating Income | $31,325 | $(358,722) |
| Net Income | $188,407 | $84,544 |
| Earnings Per Share (Diluted) | $0.04 | $0.02 |
| Cash and Cash Equivalents | $5,569,437 (End of Period) | $5,569,437 (End of Period) |
| Total Debt (Current + Long-Term) | $317,876 | $317,876 |
| Working Capital | $26,377,767 | $26,377,767 |
Liquidity: The company maintains a strong current ratio of 5.42 to 1. Cash and marketable securities totaled approximately $13.23 million at the end of the quarter.
Material Changes vs. Prior Period
- Revenue: Quarterly sales decreased 1% year-over-year (YoY) to $10.53 million. Six-month sales decreased 8% YoY to $20.58 million. Domestic sales declined, while international sales increased 13% YoY.
- Profitability: Despite lower sales, Gross Profit increased 7% YoY in the quarter due to improved product mix and margins (41% vs. 38% prior year). However, Operating Income for the six-month period turned negative ($-358k) compared to a positive $709k in the prior year, driven by a 9% increase in operating expenses.
- Net Income: Quarterly Net Income improved 37% YoY to $188k. However, six-month Net Income dropped significantly to $85k compared to $716k in the prior year.
- Expenses: Selling, General, and Administrative (SG&A) and R&D expenses increased 7% in the quarter and 9% over six months, attributed to increased sales personnel, R&D projects, and IT requirements.
- Cash Flow: Net cash provided by operating activities for the six months was $1.55 million, down from $2.75 million in the prior year. Net cash used in investing activities decreased to $0.55 million due to net purchases of securities.
Outlook, Risks, and Management Commentary
- Management Commentary: Management attributes improved gross margins to product mix and specific performance in QLS and Grass Instrument lines. The decline in operating income is linked to strategic spending on sales, marketing, and new product development.
- Share Repurchases: The company purchased 90,500 shares of common stock in the first six months. The Board has authorized the repurchase of an additional 311,176 shares.
- Dividends: Cash dividends of $0.04 per share were declared for both the first and second quarters.
- Year 2000 (Y2K) Risk: The company identifies Y2K compliance as a material risk. Estimated total costs to address Y2K issues are $822,288, with $552,288 incurred to date. Completion is expected by April 1999 for internal systems.
- Safe Harbor: Forward-looking statements are subject to risks including economic conditions, competitive pricing, product mix changes, and component shortages.
Investor Verification Checklist
- Verify the sustainability of the 41% gross margin given the 8% decline in six-month revenue.
- Confirm the timeline and budget adherence for Year 2000 compliance, specifically the $270,000 remaining estimated cost.
- Monitor the impact of increased SG&A and R&D spending on future operating income, as six-month operating income is currently negative.
- Review the composition of "Other Income" ($223k for the quarter), which significantly boosted net income, to ensure it is not a one-time anomaly.
- Assess the company's ability to maintain liquidity while continuing share repurchases and dividend payments amidst lower operating cash flow.